Forte Book Value Per Share from 2010 to 2024

FBRX Stock

USD 23.46 1.75 8.06%

Forte Biosciences Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 26.57 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Forte Biosciences according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

27.96393212

Current Value

26.57

Quarterly Volatility

533.24508794

Credit Downgrade

Yuan Drop

Covid

Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 8.6 K or Interest Expense of 14.5 K, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 0.7. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.

Check out the analysis of Forte Biosciences Correlation against competitors.

For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Latest Forte Biosciences' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Forte Biosciences over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Forte Biosciences' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Forte Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 24.30 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Forte Book Value Per Share Regression Statistics

	Arithmetic Mean	546.36
	Coefficient Of Variation	97.60
	Mean Deviation	448.45
	Median	803.75
	Standard Deviation	533.25
	Sample Variance	284,350
	Range	1.9K
	R-Value	(0.58)
	Mean Square Error	203,589
	R-Squared	0.34
	Significance	0.02
	Slope	(69.03)
	Total Sum of Squares	4M

Forte Book Value Per Share History

	2024	26.57
	2023	27.96
	2022	55.83
	2021	74.36
	2020	200.37
	2019	-56.56
	2018	1086.98

Other Fundumenentals of Forte Biosciences

Tangible Book Value Per Share

Forte Biosciences Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Net Invested Capital	Capital Stock	Net Working Capital	Deferred Long Term Liab
Total Assets		0.83	-0.06	-0.74	0.57	-0.38	0.83	-0.38	-0.15	0.6	1.0	0.24	0.7	0.61	-0.1	-0.24	-0.28	-0.35	-0.26	0.38
Total Stockholder Equity	0.83		-0.49	-0.53	0.24	-0.22	0.54	-0.22	0.17	0.06	0.85	0.51	0.35	0.17	-0.17	0.25	0.23	0.08	0.24	-0.01
Net Debt	-0.06	-0.49		-0.06	0.04	-0.4	0.42	-0.4	-0.79	0.6	-0.08	-0.26	0.04	0.69	0.47	-0.82	-0.83	-0.53	-0.83	0.5
Retained Earnings	-0.74	-0.53	-0.06		-0.73	0.32	-0.53	0.32	0.0	-0.57	-0.73	-0.47	-0.77	-0.49	0.34	0.21	0.24	0.05	0.24	-0.04
Accounts Payable	0.57	0.24	0.04	-0.73		0.0	0.32	0.0	0.22	0.7	0.55	0.09	0.96	0.33	-0.59	-0.35	-0.36	-0.27	-0.35	0.32
Long Term Debt	-0.38	-0.22	-0.4	0.32	0.0		-0.56	1.0	0.58	-0.38	-0.39	0.14	-0.03	-0.68	-0.62	0.58	0.55	0.57	0.54	-0.51
Short Term Investments	0.83	0.54	0.42	-0.53	0.32	-0.56		-0.56	-0.61	0.72	0.83	0.07	0.48	0.87	0.29	-0.61	-0.63	-0.6	-0.62	0.55
Long Term Debt Total	-0.38	-0.22	-0.4	0.32	0.0	1.0	-0.56		0.58	-0.38	-0.39	0.14	-0.03	-0.68	-0.62	0.58	0.55	0.57	0.54	-0.51
Capital Surpluse	-0.15	0.17	-0.79	0.0	0.22	0.58	-0.61	0.58		-0.51	-0.13	0.33	0.11	-0.78	-0.71	0.65	0.65	0.63	0.64	-0.58
Total Liab	0.6	0.06	0.6	-0.57	0.7	-0.38	0.72	-0.38	-0.51		0.57	-0.28	0.77	0.87	0.05	-0.81	-0.83	-0.75	-0.83	0.71
Total Current Assets	1.0	0.85	-0.08	-0.73	0.55	-0.39	0.83	-0.39	-0.13	0.57		0.25	0.68	0.6	-0.08	-0.23	-0.26	-0.34	-0.25	0.37
Common Stock	0.24	0.51	-0.26	-0.47	0.09	0.14	0.07	0.14	0.33	-0.28	0.25		0.07	-0.23	-0.45	0.43	0.43	0.68	0.41	-0.59
Property Plant Equipment	0.7	0.35	0.04	-0.77	0.96	-0.03	0.48	-0.03	0.11	0.77	0.68	0.07		0.44	-0.54	-0.37	-0.38	-0.35	-0.38	0.33
Current Deferred Revenue	0.61	0.17	0.69	-0.49	0.33	-0.68	0.87	-0.68	-0.78	0.87	0.6	-0.23	0.44		0.47	-0.81	-0.84	-0.74	-0.83	0.71
Short Term Debt	-0.1	-0.17	0.47	0.34	-0.59	-0.62	0.29	-0.62	-0.71	0.05	-0.08	-0.45	-0.54	0.47		-0.39	-0.41	-0.41	-0.41	0.38
Net Tangible Assets	-0.24	0.25	-0.82	0.21	-0.35	0.58	-0.61	0.58	0.65	-0.81	-0.23	0.43	-0.37	-0.81	-0.39		0.99	0.84	0.98	-0.72
Net Invested Capital	-0.28	0.23	-0.83	0.24	-0.36	0.55	-0.63	0.55	0.65	-0.83	-0.26	0.43	-0.38	-0.84	-0.41	0.99		0.81	1.0	-0.71
Capital Stock	-0.35	0.08	-0.53	0.05	-0.27	0.57	-0.6	0.57	0.63	-0.75	-0.34	0.68	-0.35	-0.74	-0.41	0.84	0.81		0.78	-0.89
Net Working Capital	-0.26	0.24	-0.83	0.24	-0.35	0.54	-0.62	0.54	0.64	-0.83	-0.25	0.41	-0.38	-0.83	-0.41	0.98	1.0	0.78		-0.68
Deferred Long Term Liab	0.38	-0.01	0.5	-0.04	0.32	-0.51	0.55	-0.51	-0.58	0.71	0.37	-0.59	0.33	0.71	0.38	-0.72	-0.71	-0.89	-0.68

Click cells to compare fundamentals

About Forte Biosciences Financial Statements

Forte Biosciences investors use historical fundamental indicators, such as Forte Biosciences' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	27.96	26.57
Tangible Book Value Per Share	27.96	26.57

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC